Work

Abstract PS1-10-24: Compare the Data Differences between Dosing Groups in Patients with Advanced or Recurrent HR+/HER2- Breast Cancer Treated with Ecirciclib (BPI-1178) Combined with Endocrine Therapy

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-10-24

Authors: Y. Du, J. Zhang, J. Wu, C. Hu, W. Chen, Y. Li, M. Yan, H. Li, W. Li, Y. Teng, T. Huang, Y. Lu, Y. Liu, D. Zhang, J. Peng, F. Gao, T. Wang, W. Zhang

Institutions: Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Anhui Provincial Hospital, Third Hospital of Nanchang, Chongqing University, Chongqing Cancer Hospital, Zhengzhou University, Henan Cancer Hospital, Peking University Cancer Hospital, First Hospital of Jilin University, First Hospital of China Medical University, China Medical University, Wuhan Union Hospital, Huazhong University of Science and Technology, Guangxi Medical University, Tumor Hospital of Guangxi Medical University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129411342

Cites:

Cited by:

Related to: